The largest human trial had only 16 test subjects, which means that if BPC-157 had, say, a 1% risk of a truly catastrophic side effect, a test like that would have a very small chance of catching it
These changes often even out when eating habits become steady over time
This means that the medication may no longer provide the therapeutic benefits required, rendering your treatment less effective or even useless
Ozempic (Semaglutide) mimics the GLP-1 hormone, slowing gastric emptying and helping the body release insulin more effectively after meals
Tirzepatide also has another hormone-mimicker in it called glucose-dependent insulinotropic polypeptide in it (GIP), which is why it's sometimes called a "twincretin" drug
All doses of tirzepatide increased the number of achieved standard and intensive targets compared with semaglutide